MDLN — Medline Inc. stock price, charts and financials

QT29Medline Inc.

Medline Inc. (NASDAQ: MDLN) is a Healthcare company in the Medical - Instruments & Supplies industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
31.64
-0.48-1.49%
MDLNQT29Medline Inc.·NASDAQ
31.64-1.49%
News
Down 1.5% — Kaplan Fox Encourages Medline Inc. (MDLN) Investors to Contact the Firm Regarding a Securities Investigation (newsfilecorp.com).
Medium confidence
TA
Loading chart...
Signal & projected range
QT Score downgradeHistorical pattern — not a prediction
Range still being built for this setupWe don’t yet have a frozen historical track record for qt score downgrade to describe a reliable spread of outcomes. The projected range appears once its backtest is established.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
Index-P/E36.79EPS (ttm)0.86Insider Own49.37%Shs Outstand845.61MPerf Week-2.74%
Market Cap26.75BForward P/E20.13EPS next Y1.57Insider Trans-7.98%Shs Float540.04MPerf Month-6.69%
Enterprise Value36.65BPEG3.26EPS next Q0.34Inst Own-Short Float7.31%Perf Quarter-11.96%
Income691.00MP/S0.89EPS this Y73.52%Inst Trans-Short Ratio4.82Perf Half Y-27.41%
Sales29.94BP/B1.40EPS next Y5.35%ROA1.76%Short Interest39.48MPerf YTD-24.67%
Book/sh22.56P/C9.99EPS next 5Y11.30%ROE5.45%52W High50.88 -37.81%Perf Year-
Cash/sh3.17P/FCF13.58EPS past 3/5Y-ROIC4.04%52W Low31.49 0.48%Perf 3Y-
Dividend Est.-EV/EBITDA14.39Sales past 3/5Y9.85% -Gross Margin25.02%Volatility4.10% 3.78%Perf 5Y-
Dividend TTM-EV/Sales1.22EPS Y/Y TTM-43.42%Oper. Margin6.07%ATR (14)1.41Perf 10Y-
Dividend Ex-Date-Quick Ratio2.61Sales Y/Y TTM17.38%Profit Margin2.31%RSI (14)35.89Recom2.15
Dividend Gr. 3/5Y-Current Ratio4.33EPS Q/Q51.52%SMA20-7.46%Beta0.61Target Price44.50
Payout13.89%Debt/Eq0.65Sales Q/Q11.60%SMA50-12.83%Rel Volume2.69Prev Close32.12
Employees45,000LT Debt/Eq0.65EarningsNov 04SMA200-22.14%Avg Volume7.41MPrice31.64
IPO DateDec 17, 2025Option/ShortYes / YesEPS/Sales Surpr.41.87% 2.21%Net Debt/EBITDA4.05Volume19,947,103Change-1.49%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-27-26ReiteratedBTIGBuy$50$55
Aug-06-26ReiteratedRobert W. Baird$45$42
Aug-06-26ReiteratedStifel Nicolaus$50$45
Aug-06-26ReiteratedBMO CapitalOutperform$54$47
Aug-06-26ReiteratedDeutsche Bank$42$37
Aug-06-26ReiteratedRBC CapitalOutperform$47$46
Aug-06-26ReiteratedEvercore ISI GroupOutperform$55$39
Jun-03-26ReiteratedRobert W. Baird$57$45
Jun-01-26ReiteratedBarclaysOverweight$50$45
May-07-26ReiteratedDeutsche Bank$48$42
Latest News· Times ET
Sep-18-26
Sep-16-26
Sep-15-26
Sep-14-26
Sep-13-26
Sep-10-26
Sep-08-26
Sep-07-26
Sep-04-26
Company

Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
Total Revenue29,93928,43225,507
Cost of Goods Sold Incl. D&A22,44720,91419,216
Gross Profit7,4927,5186,291
Selling, General and Administrative Excl. Other4,9044,5244,041
Research and Development0067
Other Operating Expense772782-42
Operating Income1,8162,2122,225
Interest Expense7278121,309
Unusual Expense
Non-Operating Income (Expense)-12-152330
Net Income Before Taxes1,0771,2481,246
Income Taxes1979146
Consolidated Net Income6911,1591,200
Net Income From Continuing Operations8801,1571,200
Net Income6911,1591,200
EPS (Recurring)0.861.431.52
EPS (Basic, Before Extraordinaries)0.861.431.52
EPS (Diluted)0.861.431.52
EBITDA2,5481,9523,532
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio36.7929.37
Price To Sales Ratio0.911.20
Gross Margin25.0226.4424.66
Operating Margin6.077.788.72
Net Margin2.314.084.70
Shares Outstanding857812787
Market Capitalization27,11534,104
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$52.74$46.78$40.81$34.85$28.89 Close Price0.00M549.65M1099.30M1648.96M2198.61MUSD Trades VolumeSepOctNovDec2026FebMarAprMayJunJulAugSep
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
BCP 8 Holdings Mozart Manager L.L.C.10% OwnerMay 28 '26Sale36.5433,317,8241,217,349,9941,539Jun 01
Carlyle Group Inc.10% OwnerMar 10 '26Sale41.0026,105,8401,070,339,440127,567,724Mar 12
BCP 8 Holdings Mozart Manager L.L.C.10% OwnerMar 10 '26Sale40.5127,852,9861,128,268,7561,539Mar 12
Mozart Aggregator II LP10% OwnerDec 18 '25Sale18.7120,417,040381,911,07672,372,632Dec 22
Carlyle Group Inc.10% OwnerDec 18 '25Sale29.0019,136,333554,953,657145,924,924Dec 22
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.